We are pleased to announce InCHIP’s HIV Research Interest Group Programming for 2018!
Please check back frequently, additional events and programs may be forthcoming
Lisa Eaton, PhD
Date: Thursday, January 25, 2018
Time: 2:00 – 3:00pm
RSVP for this Discussion
“Roundtable Discussion: Ideas for Stigma Intervention Development”
Although it is acknowledged that stigma serves as a barrier to beneficial health outcomes, there are few developed and available interventions to address stigma. At this roundtable discussion, we will review different intervention points for stigma (e.g., individual, group, community, structural) and different intervention models for delivering stigma focused content.
Christopher Gordon, PhD
Date: Monday, February 12, 2018
Time: 9:00 – 10:15am
RSVP for this Webinar
“Spring Webinar to Discuss NIH Funding Priorities in HIV Prevention Science”
In this webinar, Christopher Gordon, Branch Chief of the Division of AIDS Research at the National Institute of Mental Health, will outline NIH’s funding priorities in HIV Prevention Science. This will include a review of current and future funding opportunities as well as identifying future trends in the world of HIV Research. The format will be composed of a 45-minute presentation with a 15-20 minute interactive Q&A session to follow.
David Fiellin, M.D.
Date: Tuesday, March 27, 2018
Time: 12:00pm – 1:30pm
RSVP for this Lecture
“Is It Harder to Change Patient or Provider Behavior?: Lessons for Addiction and HIV Research from Implementation Science”
This talk will provide an overview and introduction to Implementation Science. This will be followed by a discussion of examples of ongoing Implementation Science research studies addressing substance use in HIV clinics and untreated opioid use disorder in Emergency Departments. Finally, the talk will discuss opportunities for training, partnership and research collaboration through the New England HIV Implementation Science Network.
William Darrow, PhD
Date: Thursday, March 29, 2018
Time: 2:00 – 3:30pm
RSVP for this Discussion
“From Patient 0 to Getting to Zero — A Brief History of the AIDS Epidemic”
With the announcement of “highly active” anti-retroviral therapy (HAART) in 1996, the focus of HIV prevention efforts and federal funding in the United States shifted from the promotion of “safer sex” and ABC (Abstinence, Be faithful, and use a Condom) messaging for behavior change to programs predicated on conceptualizations of “treatment as prevention,” “high-impact [biomedical] interventions,” and “pre-” and “post-exposure prophylaxis.” Policies and programs turned away from the community mobilization model of a “new public health” as outlined in the Ottawa Charter (1986) and implemented through “community planning” by state and local health departments in the mid-1990s towards a narrowly defined but politically more practical—and palatable—biomedical model for the 21st century. This roundtable discussion is meant to be provocative by reviewing the post-HAART history of the AIDS epidemic in the United States, plausible explanations for the more recent turn of events, and the effectiveness of HIV-prevention programs.